Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once NWBO get approval for GB other registration trials for other types of solid tumor cancers should be quick and relatively easy.
I get it. Replimune has some cancer candidates and has had a good run this year. No one is posting or paying attention on the REPL ihub board so posting here instead. However this is still the NWBO board.
Clay Traders follows are day traders that will play long and short. If it holds $1.60 they might go long there. If it fails at $1.83 they might short there and cover $1.60. If breaks $1.83 they might go long there sell a peak... all intraday. CT gets a bad rap because he posts about stocks that had parabolic gains which have a tendency to consolidate therefore offer a nice day trade. Day traders look for volitility only. Net effect is usually meaningless to investors.
It seems like Leronlimab is a broadly active anti-inflammatory.
It is said that inflammation is at the core of many diseases besides NASH. RA ALZ Heart Disease! Don't stop there. But hold the shares forever after the first approval because many more might be coming.
Gramercy Capital...look it up.
One does not run a 5 billion dollar Investment fund and get something so basic so wrong. Joan Lappin is the head of a 5 billion investment fund. I will take her word over yours especially since I have been down this road dozens of times in the last 35 years. Believe what you want to believe.
Merry Christmas
Joan Lappin is an expert on whether on not NWBO needed to report a Failed Trial of their lead compound. With 5 billion assets under management if she was unsure she would have the best legal counsel to advise her. Negative news that is material must be reported immediately under common law not regulations. The SEC 4 day rule in effect gives them a grace period of 4 days by defining immediately.
Joan put in writing that her investors can rely on the assertion that if the trial failed NWBO would have had to report it.
You can take that to the Bank.
Revenues from drip sales or upfront licensing fees in an amount that the company will never have to raise more cash with stock sales is the major reason. This will lead to steady and increasing institutional buying for mutual funds and inclusion into Index Funds. A breakaway gap with many potential catalysts looming in the near term. But short term dips on shorting should be seen as an opportunity to accumulate more shares if one has done proper DD and all fundamentals are still a go.
If the stock breaks out and is shorted again at a much higher price that could trap existing short shares at a much higher price because the price point that the new shorts want to cover so in effect puts a price floor much higher than the earlier short sellers break even point.
This chart shows a possible bull flag pattern that portends a possible move to over $9 in the next 5 to 8 trading days. This one is fueled by news. The last big move that pushed to $10 came on no news whatsoever just eerie quiet for the company.
I will not sell this coming pop. Last one could have been good for a day trade or two day swing but this next one could be followed by a Krakatoa like explosion for Philippine EUA, NAZ Uplift or Trading Day breaking news on Major Media.
When CYDY up lists to Nasdaq all shorts shares will need to be covered. It will not be a margin call they can satisfy with more cash or any other way. All short shares must be repurchased while the stock is trading as CYDYD and can not be re-shorted until after the shares have been converted to the new cuspid number on Nasdaq and symbol reverts to CYDY again. The reason is all OTC shares will go to the share transfer agent for conversion. Any naked short shares will be exposed. A short seller might not even know the shares they shorted were naked.
A few years ago Goldman Saks was caught in naked short scheme. GS was not shorting them they were counterfeiting them by loaning out for high percentage interest shares they did not have. These naked shares will have to get eliminated as CYDY is not going to have an offering whereby the broker-dealers that loaned out shares they did not have can buy an inventory of shares to cover their naked shares they counterfeited so they could loan them out.
Nader is a compassionate man.
The most compassion he could show the short sellers now would be to up list to Nasdaq on Monday to quickly execute a forced cover otherwise it will get extremely painful as shorts try to cover and roll up to re-short higher to recoup losses.
My brokers are publishing that the 10K is coming 12-28-20. If NWBO gets that monkey off its back NWBO might rise into the $2s again on Monday.
Thanks Chuckles You are the man!
I know some Doctors in the Midwest US are Rx Ivermictin for Covid. They tell the patient when asked by the Pharmacist what it is for that the patient to reply "worms."
I would explain to to you. However I am reminded of an old axiom. "One can educate the ignorant but there is no cure for stupid"
Merry Christmas and I mean that. Everyone deserves Joy in this life.
Thank you. I appreciate your charts, very well done. I would say NWBO definitely broke out to the upside of the pennant formation you illustrated so well. With that strong of a break out on 3 times average volume on a half day trading (6x volume?) I do not think the Genie goes back in the bottle of the pennant trading range easily.
Ok lets see Clay Traders simplistic take on this if he is not off for holiday. Ok I will do it for him. CLAY WILL SAY: "Ideal level of support $1.67 makes chart look strongest. More importantly just watch that purple line the famous 50 period MA currently $1.40 but as time goes on it will move higher and higher. Levels of resistance Right there where party stopped at $1.83."
Ok everyone that's Clay's take.
My take is no meaningful resistance until $2.30-2.50 zone. Supports 1st $1.67 2nd mid $1.50s.
RSI is at 68% and rising into the power zone. Last time this happened was in the $2.51 run up. Fisher Transform just crossed up from the negative to positive and in in the middle heading north. NWBO price just reentered the upward sloping regression channel that started in August 20. NWBO has room to move up and still be within a long established trading channel. It is at the bottom of that channel now. It NWBO can hold the channel It might creep up at a minimum while we wait. Technical only. Fundamentals will trump
That is a lot of Stocking Stuffers from clients of Joan Lappin of Gramercy Capital.
Question: Will the Lancet still publish its weekly Thursday issue this week, but maybe on Friday? Top line and publication can come any week now.
I would not want to be light on shares when that happens so I will not sell this pop. Last time on the run to $2.51 it ran for 5 days and reached more than 2 standard 50 cent deviation above the upward sloping regression channel. A similar run from here could take NWBO above $3.50 and make a prospect of up listing to the NASDAQ come into view. Possibly before TLD release.
Merry Christmas to the Longs here.
Is there a pre print of the Scientific publication released on Internet?
Good essay. I agree. Your post is definitely worth a read.
On another note: HGEN had been running like CYDY over the last few days and was hit with a sell off an hour and a half earlier right at the open and has 70% recovered starting about one hour ago.
Still net short more than 20 million shares. Just mitigated some losses by rolling the shorts higher. They are still totally at risk for unlimited losses as there are no long calls options to use as a hedge.
If that was shorts they have not pocketed anything until they buy the shares back. Lets see if they have the cajones to hold short overnight with positive catalysts or possible NAZ up lift looming any day.
100% correct. Stock got ahead of its self a little. It is still climbing in a steep channel. Today is just gyrations within the upwards sloping channel.
16.8 million shares traded in 1st 2.5 hours with 4 hours left to trade. Lets see what power hour brings. Volume increase often leads to price increase. This consolidation might lead to another sharp move higher.
Up List to NAZ can come without notice as early as tomorrow morning. I would not want to be light on shares overnight.
The good news is as someone smartly posted this morning this consolidation will give leads to the surge upward.
That is exactly right because stop loss orders are visible to market makers so it is like taking candy from a baby. One needs to set mental stops or stop limit orders that are only visible to your broker. Then it is only your broker that can rob you.
Those that locked in profits with stop losses might feel good for a few hours but they might have been kicked off the rocket for the next stage up.
HF trading Algos picking up shares from stop losses and nervous Nellys
7.4 million shares in 1st one hour. Any dip will give legs to the run. Not slowing down except to get more longs buying in.
So Nader was telling the truth when he said FDA was trying to help CytoDyn get to full enrollment. The FDA likely knew of the generous hearts and commpasion of Nader and Scott and did not want them to be distracted. FDA knows it seems that Leronlimab will be a critical drug in the Covid War.
Once we get above $10 there will be massive support at $10.01.
Looks like we have ignition on the first stage of a multistage rocket. Next stage Covid S2C readout or NASH full enrollment or longhauler enrollment. Choose any and the 3rd stage will follow on after.
Only 60 patients NASH trial. 1st Dec 2nd.
We could fill that trial before we have readout on CD012 S2C Covid trial.
All he was doing was cashing his paycheck for over 4 years of work. I expect everyone you works for me to cash his or her paycheck.
Boris and Natashia. Don't worry Rocky and Bullwinkle will stop them before they corner the Market for the Anavex boxtops. ??
One would intuitively think that one would do better trading in tax advantaged accounts but in practice that is often not the case. No taxes on gains but can not offset gains with losses. Also do not get the $3000 yearly deduction for harvested losses.
One should be careful on the lots characterization or choice. Default on all not specified trading lots is the one most favorable to the IRS..FIFO. To maximize long term gains one might use LIFO as as brokerage setting or to minimize taxable gains HiCost and of course be mindful of wash trade rules. To do that need to control FOMO and exercise patience and minimize trading for maximum gains. Also can only sell covered calls in tax advantaged accounts so can not use the most advantageous risk management and leverage of options.
Yes that is right. The options needed to be exercised before they expired. 50% of one traunch had already expired. CYDY received funds for the options without increasing the outstanding fully diluted share count.
Nader earlier this year was asking warrant holders to exercise so Company would receive funds. The officers were just doing what they were requesting investors do.
Wrong! Totally illogical and ridiculous post. Rule 10b-1 trading plan. The broker made the decision to sell. Anyone that can read and comprehend English can read it and see what it was. Note 1 in the green print.
Actually the CFO had ZERO impute into the decision to sell the stock. His broker made the decision and was the only one who by law and contract had any say in the decision whatsoever. The sale was according to a Rule 10b-1 trading plan. Those options were granted so they could be exersized and sold to compenate the CFO. Everything worked as it was designed. CYDY recieved money for the option exercise and Mulholland was compensated for his work the last at least 4 years.
Now the stockholders have that much less option overhang on the outstanding shares. It was a Win Win Win for everyone.